Expression profiling of gastric adenocarcinoma using cDNA array.

Gastric adenocarcinoma: review and considerations for future directions. Ann Surg (2005) 3.83

Variation in gene expression patterns in human gastric cancers. Mol Biol Cell (2003) 2.39

An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res (2010) 1.73

Protein S100A4: too long overlooked by pathologists? Am J Pathol (2002) 1.59

Aberrant expression of RAB1A in human tongue cancer. Br J Cancer (2005) 1.40

Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut (2004) 1.22

Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg (2006) 1.07

Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer (2005) 1.03

Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol (2008) 0.98

Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis. World J Surg (2012) 0.94

Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form. J Mol Biol (2008) 0.93

Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer (2002) 0.93

Clustering of molecular alterations in gastroesophageal carcinomas. Neoplasia (2004) 0.91

Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip. World J Gastroenterol (2005) 0.85

cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. World J Surg (2014) 0.83

Microarray analysis in gastric cancer: a review. World J Gastroenterol (2014) 0.83

EB1 levels are elevated in ascorbic Acid (AA)-stimulated osteoblasts and mediate cell-cell adhesion-induced osteoblast differentiation. J Biol Chem (2013) 0.82

Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer. BMC Gastroenterol (2013) 0.81

mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray. World J Gastroenterol (2006) 0.81

Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics (2007) 0.80

Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability. World J Gastroenterol (2005) 0.79

Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer. Int J Exp Pathol (2003) 0.76

Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol (2003) 0.76

Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment. Medicine (Baltimore) (2016) 0.75

Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52

Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res (2001) 6.78

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res (2001) 6.73

The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65

Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet (1997) 4.27

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med (1990) 3.21

Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res (1999) 2.88

Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62

Increased expression of high mobility group A proteins in lung cancer. J Pathol (2006) 2.39

Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38

A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol (1992) 2.34

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33

Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res (1998) 2.20

Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19

Activating c-kit gene mutations in human germ cell tumors. Am J Pathol (1999) 2.15

Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem (1996) 2.12

Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia (2007) 2.11

Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11

Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09

Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate (2001) 2.04

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99

The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res (2005) 1.89

Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol (1991) 1.89

Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85

Familial aniridia and translocation t(4;11)(q22;p13) without Wilms' tumor. Hum Genet (1983) 1.83

Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol (1986) 1.82

A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br J Clin Pharmacol (1998) 1.82

Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet (1997) 1.77

Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol (1993) 1.76

ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. Hum Reprod (2004) 1.75

Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology (2001) 1.74

Mucinous cystadenoma of the lung. A report of two cases with immunohistochemical and ultrastructural analysis. Arch Pathol Lab Med (1990) 1.71

Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A (2000) 1.69

DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer (1998) 1.66

ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod (2010) 1.65

Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol (1989) 1.60

Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet (2000) 1.59

Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci (2001) 1.57

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res (2004) 1.56

Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet (2001) 1.55

Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother (2001) 1.53

Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene (1999) 1.52

DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res (2000) 1.51

Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol (1999) 1.49

Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49

Detection of Helicobacter pylori DNA in fecal samples from infected individuals. J Clin Microbiol (1999) 1.48

BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A (2001) 1.48

Prevalence of Campylobacter species, Helicobacter pylori and Arcobacter species in stool samples from the Venda region, Limpopo, South Africa: studies using molecular diagnostic methods. J Infect (2006) 1.47

cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland. J Mol Biol (2001) 1.44

A 20-minute breath test for helicobacter pylori. Am J Gastroenterol (1991) 1.43

Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology (1994) 1.41

Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol (1992) 1.41

KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol (1999) 1.40

Colony formation by megakaryocyte progenitors in myelodysplatic syndromes. Eur J Haematol (1989) 1.39

Guardians of the wax ... and the patient. Mod Pathol (1995) 1.38

Immunophenotyping and molecular cytogenetics. J Histochem Cytochem (1992) 1.38

The inheritance of fragile sites: apparent absence of fra(2)(q13) in the parents of three unrelated probands. J Med Genet (1987) 1.38

ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum Reprod (2009) 1.35

ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod (2010) 1.35

A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria. Am J Trop Med Hyg (1998) 1.35

Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res (1995) 1.34

DNA copy number changes in diffuse large B-cell lymphoma--comparative genomic hybridization study. Blood (1996) 1.34

The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod (2009) 1.33

Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol (2001) 1.32

Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem (1996) 1.32

Nonpalpable invasive breast cancer. Ann Surg (1991) 1.29

DNA copy number amplification profiling of human neoplasms. Oncogene (2006) 1.25

ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod (2010) 1.22

Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut (2004) 1.22

A practical metaphase marker of the inactive X chromosome. Am J Hum Genet (1986) 1.20

Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res (2002) 1.19

Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer. Oncogene (2006) 1.19

Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer (1997) 1.19

BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood (1997) 1.18

Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene (2006) 1.17

Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet (1993) 1.16

Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia (2001) 1.16

Comparative genomic hybridization analysis of human oocytes and polar bodies. Hum Reprod (2006) 1.16

DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer (1999) 1.15

Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer (1997) 1.14

Sinonasal undifferentiated carcinoma: a distinctive and highly aggressive neoplasm. Laryngoscope (1987) 1.13

Pallister-Killian syndrome: cytogenetic and molecular studies. Clin Genet (1987) 1.13

Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res (1998) 1.13

Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci U S A (1996) 1.13

Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer (1996) 1.13

Prognostic impact of chromosomal aberrations in Ewing tumours. Br J Cancer (2002) 1.13

Analysis of the evolution of chromosome abnormalities in human embryos from Day 3 to 5 using CGH and FISH. Mol Hum Reprod (2008) 1.12

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene (2006) 1.11

Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res (1999) 1.11

Defining a common region of deletion at 13q21 in human cancers. Genes Chromosomes Cancer (2001) 1.11

Origin of microsatellite instability in gastric cancer. Am J Pathol (1999) 1.10

Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol (1997) 1.10

Chromosome pulverization in blood diseases. Hereditas (1981) 1.10